Inhibition by SKF 525A and quinacrine of endogenous glibenclamide-sensitive K+ channels in follicle-enclosed Xenopus oocytes
- 24 January 1994
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 252 (1) , 117-121
- https://doi.org/10.1016/0014-2999(94)90583-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Antiarrhythmic drugs, clofilium and cibenzoline are potent inhibitors of glibenclamide‐sensitive K+ currents in Xenopus oocytesBritish Journal of Pharmacology, 1993
- Blockade by antiarrhythmic drugs of glibenclamide‐sensitive K+ channels in Xenopus oocytesBritish Journal of Pharmacology, 1992
- Inactivation of glibenclamide-sensitive K+ channels in Xenopus oocytes by various calmodulin antagonistsEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Divergent kinetics of 201Tl and 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion.Circulation, 1992
- Chlorpromazine and related phenothiazines inhibit the ATP-sensitive K+ channelEuropean Journal of Pharmacology, 1991
- Properties and functions of ATP-sensitive K-channelsCellular Signalling, 1990
- Acetylcholine releases endothelium‐derived hyperpolarizing factor and EDRF from rat blood vesselsBritish Journal of Pharmacology, 1988
- Endothelium‐dependent effects of acetylcholine in rat aorta: a comparison with sodium nitroprusside and cromakalimBritish Journal of Pharmacology, 1988
- Effect of SKF 525A on the release of nitric oxide and prostacyclin from endothelial cellsEuropean Journal of Pharmacology, 1988
- ATP-regulated K+ channels in cardiac muscleNature, 1983